ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹104 Cr | ₹11 Cr | ₹-2.34 Cr | ₹14 Cr | ₹-30 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ERIS LIFESCIENCES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹104 Cr |
Mar2024 | ₹11 Cr |
Mar2023 | ₹-2.34 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹-30 Cr |
How is Net Cash Inflow / Outflow of ERIS LIFESCIENCES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹104 Cr | 828.56 | |
Mar2024 | ₹11 Cr | Positive | |
Mar2023 | ₹-2.34 Cr | Negative | |
Mar2022 | ₹14 Cr | Positive | |
Mar2021 | ₹-30 Cr | - |
Compare Net Cash Inflow / Outflow of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹24,543.9 Cr | 0.5% | 10.5% | 61.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 0.5% |
10.5% |
61.5% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses